Balance Sheet for Prevail Therapeutics Inc. (PRVL)

$ 15.88   0.37 (+2.39%) Volume: 128.32k 4:00 PM EDT Aug 10, 2020
After Hours:  $ 16.00   0.12 (+0.76%) Volume: 2.5k 6:26 PM EDT Aug 10, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017
Cash and Equivalents 168,051 63,014 12,744
Restrictable Cash - - -
Marketable Securities - - -
Accounts Receivable - - -
Loans Receivable - - -
Other Receivables - - -
Receivables - - -
Inventories, Raw Materials - - -
Inventories, Work in Progress - - -
Inventories, Purchased Components - - -
Inventories, Finished Goods - - -
Inventories, Other - - -
Inventories, Adjustments & Allowances - - -
Inventories - - -
Prepaid Expenses 6,410 563 105
Current Deferred Income Taxes - - -
Other Current Assets - - -
Total Current Assets 174,461 63,577 12,849
Land and Improvements - - -
Buildings and Improvement 887 - -
Machinery, Furniture and Equipment 1,984 735 108
Construction in Progress - - -
Fixed Assets, Other 10,001 8,534 1,279
Fixed Assets, Total 12,872 9,269 1,387
Gross Fixed Assets 12,872 9,269 1,387
Accumulated Depreciation (322) (57) (2)
Net Fixed Assets 12,550 9,212 1,385
Intangibles - - -
Cost in Excess - - -
Non-Current Deferred Income Taxes - - -
Other Non-Current Assets 91 91 91
Total Non-Current Assets 12,641 9,303 1,477
Total Assets 187,102 72,880 14,326
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017
Accounts Payable 5,162 1,241 265
Short Term Debt 1,341 917 8,059
Notes Payable - - -
Accrued Expenses 2,229 273 13
Accrued Liabilities 2,229 273 13
Deferred Revenues - - -
Current Deferred Income Taxes - - -
Other Current Liabilities 3,101 1,204 2,378
Total Current Liabilities 11,833 3,635 10,715
Long Term Debt N/A N/A N/A
Deferred Income Tax - - -
Other Non-Current Liabilities - - -
Minority Interest - - -
Capital Lease Obligations 9,927 7,952 1,028
Preferred Securities of Subsidiary Trust - - -
Preferred Equity Outside Shareholders' Equity - 79,710 3,524
Total Non-Current Liabilities 9,927 87,662 4,551
Total Liabilities 21,760 91,297 15,266
Preferred Shareholder's Equity - - -
Common Shareholder's Equity 165,342 (18,417) (940)
Common Par 3 1 1
Additional Paid in Capital 249,441 2,496 885
Cumulative Translation Adjustments - - -
Retained Earnings (84,102) (20,914) (1,827)
Treasury Stock - - -
Other Equity Adjustments - - -
Total Capitalization 165,342 (18,417) (940)
Total Equity 165,342 (18,417) (940)
Total Liabilities & Shareholder's Equity 187,102 72,880 14,326
Cash Flow (63,188) (19,089) (1,827)
Working Capital 162,628 59,942 2,134
Free Cash Flow (57,890) (14,638) (1,095)
Invested Capital 165,342 (18,417) (940)
Shares Outstanding - Common Class Only 34,139 - -
Preferred Shares Outstanding - - -
Total Ordinary Shares 34,139 33,997 33,997
Total Common Shares Outstanding 34,139 - -
Treasury Shares - - -
Basic Weighted Shares Outstanding 28,495 21,771 19,044
Diluted Weighted Shares Outstanding 28,495 21,771 19,044